SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
3	Initial filing by director officer or owner of more than ten percent.	Jul 21, 2008	View HTML 0001181431-08-043856.pdf 0001181431-08-043856.rtf
8-K	Report of unscheduled material events or corporate event	Jul 14, 2008	View HTML 0001193125-08-150506.pdf 0001193125-08-150506.rtf 0001193125-08-150506.xls
EFFECT	EFFECT	Jul 14, 2008	View HTML 9999999995-08-002170.pdf 9999999995-08-002170.rtf
S-8	Securities offered to employees pursuant to employee benefit plans	Jul 03, 2008	View HTML 0001193125-08-146703.pdf 0001193125-08-146703.rtf 0001193125-08-146703.xls
POS AM	Post-effective amendment to an S-Type filing	Jul 03, 2008	View HTML 0001193125-08-146757.pdf 0001193125-08-146757.rtf 0001193125-08-146757.xls
EFFECT	EFFECT	Jul 01, 2008	View HTML 9999999995-08-002077.pdf 9999999995-08-002077.rtf
EFFECT	EFFECT	Jul 01, 2008	View HTML 9999999995-08-002078.pdf 9999999995-08-002078.rtf
3	Initial filing by director officer or owner of more than ten percent.	Jun 27, 2008	View HTML 0001181431-08-040787.pdf 0001181431-08-040787.rtf
3	Initial filing by director officer or owner of more than ten percent.	Jun 27, 2008	View HTML 0001181431-08-040788.pdf 0001181431-08-040788.rtf
3	Initial filing by director officer or owner of more than ten percent.	Jun 27, 2008	View HTML 0001181431-08-040789.pdf 0001181431-08-040789.rtf

Data provided by Kaleidoscope.